We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+20.77%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$547M
Cap. Flow
-$10.2M
Cap. Flow %
-1%
Top 10 Hldgs %
88.16%
Holding
123
New
24
Increased
19
Reduced
32
Closed
28

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$4.7M
2
ZGNX
Zogenix, Inc.
ZGNX
+$3.17M
3
WNC icon
Wabash National
WNC
+$1.87M
4
SAGE
Sage Therapeutics
SAGE
+$1.75M
5
PRTA icon
Prothena Corp
PRTA
+$1.53M

Top Sells

Rank Stock Value
1
HIMX
Himax Technologies
HIMX
+$4.17M
2
MB
MINDBODY, Inc. Class A Common Stock
MB
+$2.9M
3
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$2.74M
4
AMD icon
Advanced Micro Devices
AMD
+$2.52M
5
MYND
Mynd.ai
MYND
+$2.28M

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.39%
2 Healthcare 8.29%
3 Technology 2.88%
4 Communication Services 2.01%
5 Consumer Discretionary 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TITN icon
76
Titan Machinery
TITN
$571M
$529K 0.05%
+25,000
New +$430K
LCTX icon
77
Lineage Cell Therapeutics
LCTX
$268M
$494K 0.05%
262,376
+211,455
+415% +$462K
PRTK
78
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$473K 0.05%
26,400
– –
TELL
79
DELISTED
Tellurian Inc.
TELL
$438K 0.04%
+45,000
New +$482K
SOHU
80
Sohu.com
SOHU
$359M
$434K 0.04%
+10,000
New +$536K
PXLW icon
81
Pixelworks
PXLW
$41.7M
$373K 0.04%
+4,908
New +$333K
PTR
82
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$361K 0.04%
+5,168
New +$347K
SCTL
83
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$352K 0.03%
42,370
– –
SCYX icon
84
SCYNEXIS
SCYX
$43.7M
$329K 0.03%
1,772
– –
COHR icon
85
Coherent
COHR
$53.1B
$282K 0.03%
+6,000
New +$269K
NOAH
86
Noah Holdings
NOAH
$559M
$278K 0.03%
+6,000
New +$247K
VNET
87
VNET Group
VNET
$1.7B
$267K 0.03%
33,486
+11,986
+56% +$87.3K
DCOY
88
Decoy Therapeutics
DCOY
$1.78M
– –
0
– –
BEDU
89
DELISTED
Bright Scholar Education Holdings
BEDU
$202K 0.02%
2,700
-5,925
-69% -$517K
OVID icon
90
Ovid Therapeutics
OVID
$529M
$148K 0.01%
+15,000
New +$138K
ACMR icon
91
ACM Research
ACMR
$4.45B
$131K 0.01%
+75,000
New +$149K
AEHR icon
92
Aehr Test Systems
AEHR
$2.66B
$97K 0.01%
35,908
-22,672
-39% -$71.8K
ZSAN
93
DELISTED
Zosano Pharma Corporation
ZSAN
$78K 0.01%
214
– –
CAPR icon
94
Capricor Therapeutics
CAPR
$498M
$53K 0.01%
3,375
– –
AMD icon
95
Advanced Micro Devices
AMD
$823B
– –
-197,550
Closed -$2.52M
BZUN
96
Baozun
BZUN
$159M
– –
-8,000
Closed -$262K
DQ
97
Daqo New Energy
DQ
$762M
– –
-50,000
Closed -$290K
FENG
98
Phoenix New Media
FENG
$17.3M
– –
-6,115
Closed -$216K
HUM icon
99
Humana
HUM
$47.6B
– –
-5,000
Closed -$1.22M
INCY icon
100
Incyte
INCY
$24.7B
– –
-18,000
Closed -$2.1M
1 2 3
4
5

Similar funds

MAM
Moelis Asset Management New York $5.32M AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
SM
SG3 Management Dorado, Puerto Rico $6.45K AUM 61.81% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

Granite Point Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Granite Point Capital Management held 123 positions worth $1.02B, up 115% from $475M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Granite Point Capital Management's Q4 2017 filing shows 24 new, 19 increased, 32 reduced and 28 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 40,000 shares worth $5.28M. The largest sale was Himax Technologies, an estimated $4.17M.

By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, up from 65% a quarter earlier, followed by Healthcare and Technology.

  • Granite Point Capital Management's largest Q4 2017 buy was GW Pharmaceuticals Plc American Depositary Shares: 40,000 shares worth $5.28M.
  • Granite Point Capital Management added most to Zogenix, Inc. in Q4 2017, an estimated $3.17M increase.
  • Granite Point Capital Management's biggest Q4 2017 reduction was Himax Technologies, cutting an estimated $4.17M.
  • Granite Point Capital Management fully exited MINDBODY, Inc. Class A Common Stock in Q4 2017, selling an estimated $2.9M.
  • Granite Point Capital Management's ten largest holdings make up 88% of its $1.02B portfolio in Q4 2017.
  • Granite Point Capital Management opened 24 new positions and closed 28 in Q4 2017.
  • Granite Point Capital Management's portfolio value rose 115% quarter-over-quarter to $1.02B.

Based on Granite Point Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.